Developing tests to detect and identify drug-resistant infections.
Official title: TASK A: NIAID Preclinical Services for AMR Diagnostics Development - Product Development Processes and Documentation
Funded at Advanced Bioscience Laboratories, INC. · NIH-10913004 · Data updated 2026-11-12
This study is working on better tests to quickly and accurately find drug-resistant bacteria, so patients can get the right treatment faster and feel better sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | June 20, 2023 |
| Project end | June 19, 2030 |
| Funding year | 2023 |
| Award (this year) | $3,500 |
| NIH project number | 75N93023D00015-0-759302300002-1 |
| Project ID | NIH-10913004 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have or are suspected to have infections caused by drug-resistant bacteria.
✕Less likely to help
Patients with infections caused by non-resistant bacteria may not receive direct benefits from this research.
What this research studies
This research focuses on creating and improving diagnostic tests that can accurately detect and identify drug-resistant bacteria, particularly those that are difficult to treat. By developing advanced assays and platforms, the project aims to enhance our ability to diagnose infections caused by resistant organisms. Patients may benefit from more accurate and timely diagnoses, which can lead to better-targeted treatments and improved health outcomes. The research involves collaboration with various stakeholders to ensure the tests meet clinical needs and regulatory standards.
Why it matters
Potential benefit: If successful, this research could lead to more effective diagnostic tools for identifying drug-resistant infections, ultimately improving patient care.
How similar studies have gone: Other research has shown success in developing diagnostic tests for infectious diseases, indicating that this approach has potential for impactful outcomes.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Mayer, Christina — Advanced Bioscience Laboratories, INC.
- Study coordinator: Mayer, Christina
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.